All In Biotech

Free tool

FAERS Monitor: Potassium Acetate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018896 or its brand name (Potassium Acetate, Potassium Acetate). Reports on generic versions are filed under their own applications.

Reports

1,458

Serious

1,056

72% of reports

Hospitalization

561

Death reported

160

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea109
  • diarrhoea108
  • nausea108
  • fatigue103
  • asthenia85
  • dizziness84
  • drug ineffective84
  • headache61
  • weight decreased60
  • death57
  • pain57
  • vomiting57
  • fall54
  • pneumonia54
  • pyrexia52

Reports by year received

View as table
YearReports
20048
200590
2006242
2007424
20082
20094
20104
201175
201296
201312
20148
201517
201639
201731
201856
201962
202055
202134
202238
202326
202442
202534
202659

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,701 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
astheniaSignal853.32.7133
weight decreasedSignal603.12.484
dyspnoeaSignal1092.82.3126
dizzinessSignal842.42.071
diarrhoeaSignal1082.42.091
pneumoniaSignal542.41.944
fallSignal542.31.841
pyrexiaSignal522.21.732
nausea1082.01.652
fatigue1031.91.645
vomiting571.71.418
headache611.41.17
pain571.31.05
death571.00.70
drug ineffective840.90.71

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.